Back to Search
Start Over
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes].
- Source :
-
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2007 Dec; Vol. 132 (49), pp. 2650-3. - Publication Year :
- 2007
- Subjects :
- Animals
Cardiovascular Diseases prevention & control
Diabetes Mellitus, Type 2 complications
Dyslipidemias complications
Dyslipidemias drug therapy
Fractures, Bone etiology
Glycated Hemoglobin metabolism
Humans
Hypoglycemic Agents adverse effects
Lipids blood
Osteoporosis, Postmenopausal chemically induced
Osteoporosis, Postmenopausal complications
PPAR gamma drug effects
PPAR gamma physiology
Pioglitazone
Risk Assessment
Risk Factors
Rosiglitazone
Thiazolidinediones therapeutic use
Cardiovascular Diseases chemically induced
Diabetes Mellitus, Type 2 drug therapy
Hypoglycemic Agents therapeutic use
Insulin Resistance
Thiazolidinediones adverse effects
Subjects
Details
- Language :
- German
- ISSN :
- 1439-4413
- Volume :
- 132
- Issue :
- 49
- Database :
- MEDLINE
- Journal :
- Deutsche medizinische Wochenschrift (1946)
- Publication Type :
- Academic Journal
- Accession number :
- 18050033
- Full Text :
- https://doi.org/10.1055/s-2007-993115